SB

Sprout BioVentures

North America, Massachusetts, United States, Cambridge

Description

Sprout BioVentures invests in early-stage opportunities.

Investor Profile

Sprout BioVentures has made 3 investments, with 0 in the past 12 months and 67% as lead.

Stage Focus

  • Series A (33%)
  • Series Unknown (33%)
  • Seed (33%)

Country Focus

  • Canada (67%)
  • United States (33%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Therapeutics
  • Gaming
  • Ios
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sprout BioVentures frequently co-invest with?

MaRS Investment Accelerator Fund
North America, Ontario, Canada, Toronto
Co-Investments: 1
BDC Capital’s Women in Technology Venture Fund
North America, Quebec, Canada, Montréal
Co-Investments: 1
GS
North America, Washington, United States, Bellevue
Co-Investments: 1
MBX Capital
North America, New York, United States, New York
Co-Investments: 1
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 2
Viva Biotech
Asia, Shanghai, China, Shanghai
Co-Investments: 1
StandUp Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 1
CR Capital Management
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Viva BioInnovator
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Inveready
Europe, Catalonia, Spain, Barcelona
Co-Investments: 1

What are some of recent deals done by Sprout BioVentures?

AmacaThera

Toronto, Ontario, Canada

AmacaThera's injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes.

BiopharmaBiotechnologyTherapeutics
Series AFeb 22, 2021
Amount Raised: $10,300,000
Mebias Discovery

Philadelphia, Pennsylvania, United States

Mebias Discovery holds a game-changing platform to discover next generation.

GamingiOS
Series UnknownOct 14, 2019
Amount Raised: $3,500,000
AmacaThera

Toronto, Ontario, Canada

AmacaThera's injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes.

BiopharmaBiotechnologyTherapeutics
SeedOct 3, 2019
Amount Raised: $2,699,045